
Please contact the doctor's office to verify that your insurance is accepted.
Dr. Bishoy Morris Faltas is an Associate Professor of Medicine and Attending in the Genitourinary Oncology Program in the Division of Hematology & Medical Oncology at Weill Cornell Medicine. Dr. Faltas is the Chief Research Officer of the Caryl and Israel Englander Institute for Precision Medicine focusing on the application of genomic approaches to clinical trials by tailoring treatment based on the unique molecular profile of each patient's cancer.
Dr. Faltas completed his Hematology and Medical Oncology Fellowship at Weill Cornell Medicine, as well as additional training through a research fellowship in the laboratory of Dr. Mark A. Rubin. During this time, he led studies of...
AI is absolutely revolutionizing how doctor's treat cancer
Deep Learning Helps Predict Treatment Response in Muscle-Invasive Bladder Cancer
Oncologist Receives Prestigious MERIT Grant from the National Cancer Institute for Bladder Cancer Research
Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models.
Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities.
Therapeutic vulnerabilities exposed by the 9p21 loss identified through multiparametric drug screening inform rational combination strategies.